Design
Review
Authors
Loading...
Underpins RAS inhibitor use in hypertension; leaves open refinement of therapies targeting remodeling.
Key points are not available for this paper at this time.
T Inagami (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: